Showing results (11-20 of 1,397) with videos related to
Sort By:
Pageof 140
Pharmacology Research & Perspectives|June 16, 2022
The sodium-glucose co-transporter 2 inhibitor tofogliflozin suppresses atherosclerosis through glucose lowering in ApoE-deficient mice with streptozotocin-induced diabetesMasahiko Iwamoto, Tetsuya Kubota, Yoshitaka Sakurai, et al.Pharmacology Research & Perspectives|January 14, 2023
Comparative evaluation of biased agonists Sarcosine1 , d-Alanine8 -Angiotensin (Ang) II (SD Ang II) and Sarcosine1 , Isoleucine8 -Ang II (SI Ang II) and their radioiodinated congeners binding to rat liver membrane AT1 receptorsNatalia M Noto, Yazmin M Restrepo, Hong W Pang, et al.Pharmacology Research & Perspectives|December 5, 2022
Suspected adverse drug reactions of the type 2 antidiabetic drug class dipeptidyl-peptidase IV inhibitors (DPP4i): Can polypharmacology help explain?Lauren Jones, Alan M JonesPharmacology Research & Perspectives|October 11, 2021
Recombinant botulinum neurotoxin serotype A1 in vivo characterizationCindy Périer, Vincent Martin, Sylvie Cornet, et al.Pharmacology Research & Perspectives|April 29, 2022
Dynamic muscle paralytic effects of a novel botulinum toxin A free of neurotoxin-associated proteinsWu-Chao Liu, Jun-Hui Su, Ya Feng, et al.Pharmacology Research & Perspectives|March 11, 2021
Casticin protected against neuronal injury and inhibited the TLR4/NF-κB pathway after middle cerebral artery occlusion in ratsDan Huang, Jiafan Zhou, Wenning Li, et al.Pharmacology Research & Perspectives|February 28, 2021
Drug discovery: Insights from the invertebrate Caenorhabditis elegansSebastián Giunti, Natalia Andersen, Diego Rayes, et al.Pharmacology Research & Perspectives|March 4, 2021
Changes in clinical trials of endocrine disorder and metabolism and nutrition disorder drugs in mainland China over 2010-2019Xin Liu, Suqin Wu, Jian Sun, et al.Pharmacology Research & Perspectives|March 11, 2021
Augmented renal clearance in critically ill patients with cancer (ARCCAN Study): A prospective observational study evaluating prevalence and risk factorsLama H Nazer, Aseel K AbuSara, Yasmeen KamalPharmacology Research & Perspectives|March 16, 2016
Slow drug delivery decreased total body clearance and altered bioavailability of immediate- and controlled-release oxycodone formulationsYan Li, Duxin Sun, Maria Palmisano, et al.Pageof 140